濮阳东方医院治早泄价格低濮阳东方技术比较专业,濮阳市东方医院在哪个地方,濮阳东方妇科价格收费合理,濮阳东方医院收费标准,濮阳东方医院公交路线,濮阳东方妇科医院做人流评价很不错,濮阳东方医院男科治疗阳痿价格不高

The White House chief of staff says President Donald Trump has tested negative for the coronavirus ahead of Thursday night’s second and final presidential debate.Mark Meadows says Trump was tested onboard Air Force One while en route to Nashville, Tennessee, and tested negative.Biden’s campaign said Thursday that he, too, was tested Thursday and tested negative.The test comes after Trump’s bout with the virus, which put him in the hospital for three nights.Both campaigns had been required to certify that their candidates and VIP guests have tested negative ahead of the debates. But Trump and the White House have repeatedly refused to say whether Trump actually was tested before participating in the first.Trump was diagnosed with the virus two days later. 772

The Supreme Court on Tuesday invalidated a provision of federal law that requires the mandatory deportation of immigrants who have been convicted of some crimes, holding that the law is unconstitutionally vague.The case, Sessions v. Dimaya, had been closely watched to see if the justices would reveal how they will consider the Trump administration's overall push to both limit immigration and increase deportations.As expected after the oral argument, Justice Neil Gorsuch joined with the more liberal justices for the first time since joining the court to produce a 5-4 majority invalidating the federal statute. In doing so, Gorsuch was continuing the jurisprudence of Justice Antonin Scalia, who also sided with liberals when it came to the vagueness of statutes used to convict criminal defendants.Only eight justices heard the case last term after Scalia's death, and in late June, the court announced it would re-hear arguments this term, presumably so that Gorsuch could break some kind of a tie.Dimaya, a native of the Philippines, was admitted to the United States in 1992 as a lawful permanent resident. In 2007 and 2009, he pleaded no contest to charges of residential burglary in California and an immigration judge determined that Dimaya was removable from the US because of his two state court convictions.The court held that the convictions qualified for an "aggravated felony" under the Immigration and Nationality Act, which authorizes removal of non-citizens who have been convicted of some violent crimes and defines aggravated felony to include "crimes of violence."Lawyers for Dimaya appealed the removal arguing that it was unconstitutionally vague and that their client never had fair notice that his crimes would result in deportation.They suggested the reasoning of a 2015 Scalia opinion, which struck a provision of the Armed Career Criminal Act as unconstitutionally vague, should extend to their case.  1945

The teenager who allegedly used a shotgun and a revolver to kill 10 people and wound 10 others at a Texas high school Friday admitted he didn't shoot people he liked and meant to kill the ones he did target, a probable cause affidavit says.Suspect Dimitrios Pagourtzis, 17, has cooperated with police, said Galveston County Magistrate Mark Henry said. Henry denied bail for the student, who is accused of capital murder of multiple people and aggravated assault on a public servant.Students at Santa Fe High School, not far from Houston in southeastern Texas, scrambled for safety after they heard shots just after class began Friday morning. Nine students and one teacher were killed, a law enforcement official told CNN.Pagourtzis said little during a video court appearance, answering "Yes, sir" when asked whether he wanted a court-appointed attorney. He was not asked to enter a plea.The probable cause affidavit says he told an investigator he spared people he liked because he wanted his story told.The alleged shooter used a shotgun and a .38 revolver that were legally owned by his father, Gov. Greg Abbott told reporters. Two school resource officers were on the campus and confronted the shooter "early on in the process," Abbott said.Live updates on the school shootingLatest developments? A student who survived being shot in the head tweeted: "I'm so greatful and blessed that god spared me today." Rome Shubert showed CNN affiliate KTRK where a bullet went in the back of his head and came out near his left ear.? A Pakistani exchange student, Sabika Sheikh, was killed, the county's embassy in Washington said.? One classmate told CNN the alleged shooter was "really quiet and he wore like a trench coat almost every day."? Abbott said investigators have found journals on a computer and cell phone owned by the suspect.? The governor offered his sympathies to the victims then called for lawmakers and others to come together to prevent more tragedies. "We need to do more than just pray for the victims and their families. It's time in Texas that we take action to step up and make sure this tragedy is never repeated ever again."? Retired Houston Police officer John Barnes was one of the people shot at Santa Fe High School, a hospital official said. Houston's police chief tweeted that he visited the hospital where Barnes was being treated and that Barnes was "hanging in there." The officer was working as a Santa Fe officer, a police union official tweeted.What we know about the shootingEarly morning attackGunfire erupted at the school, about 20 miles outside Galveston, not long after classes began around 7:30 a.m. CT, officials said. Authorities later found explosive devices -- including pipe bombs and pressure cookers -- in and near the school, the law enforcement official said.The suspect is believed to be a student. A second person -- also believed to be a student -- has been detained as well, Harris County Sheriff Ed Gonzalez said earlier.The male that Gonzalez described as a suspect was injured, a law enforcement official said on condition of anonymity.Investigators believe that the second person, an 18-year-old, may be an accomplice but not a shooter, a law enforcement official said.Two law enforcement officers are among the injured, according to a law enforcement source.One man is in critical condition with a gunshot wound in one of his arms, said David Marshall, chief nursing officer for University of Texas Medical Branch hospital.This is the 22nd US school shooting since the beginning of the year, and the third instance in eight days in which a gunman was on a school campus.Witnesses described students running from the school as they heard gunshots; they also described hearing an alarm at the school, though the sequence of events wasn't immediately clear.Authorities found explosive devices in the high school and in adjacent areas, said Walter Braun, Santa Fe Independent School District police chief. It wasn't immediately clear if any had exploded.Because the devices were found, Braun urged people in the city of about 13,000 people to "not touch any items that look out of place, and call 911" if they see something suspicious.Investigators Friday afternoon were searching a trailer where they believe the devices were assembled, a law enforcement source said.The school has been cleared of all students and staff, who have been directed to a nearby facility to reunite with their families, Braun said.Witness: Shooter fired gun in an art classAn armed person walked into an art class at the school and began firing what looked like a shotgun, a witness told KTRK.The witness told KTRK she saw a girl shot in the leg.Victims were being treated at three hospitals, authorities said. Eight people went to Clear Lake Regional Medical in Webster, Texas; two patients were treated at Mainland Medical Center in Texas City; and four patients went to John Sealy University of Texas Medical Branch in Galveston. It is unclear whether they were all wounded.Six of the eight patients at Clear Lake Regional were discharged by Friday afternoon.Witnesses describe hearing an alarm as well as gunfireAngelica Martinez, a 14-year-old student, told CNN she and her schoolmates were being evacuated at one point "like it's a fire drill.""We were all standing (outside), but not even five minutes later, we started hearing gunshots," she said. "And then everybody starts running, but, like, the teachers are telling us to stay put, but we're all just running away.""I didn't see anybody shooting, but like (the gunshots) were kind of spaced," Angelica said, adding she heard about four shots.A witness who spoke to KTRK also said she heard an alarm. She didn't specify if that was before or after the gunfire she described in the art class.She said she couldn't describe the shooter."I didn't look. I just ran," she said.Another student, Dakota Shrader, told CNN affiliate KPRC that she heard gunshots only after hearing an alarm in the school."I was in the history hallway, and as soon as we heard the alarms, everybody just started leaving following the same procedure as ... (a) practice fire drill," Shrader said, breaking into tears. "And next thing you know, we just hear ... three gunshots, loud explosions, and all the teachers are telling us to run."MaKenna Evans, a 16-year-old sophomore, told CNN she was in geometry class when the shooting started.First, she heard a fire alarm, she said. When the students got outside, her principal told them all to run.Evans said students hid behind a building across the street from the school.The high school has about 1,400 students, according to GreatSchools.org.Trump: Mass shootings have been 'going on too long in our country'Trump addressed the school shooting, saying that mass shootings have been "going on too long.""Unfortunately, I have to begin by expressing our sadness and heartbreak over the deadly shooting at Santa Fe High School in Texas," Trump said from the East Room of the White House. "This has been going on too long in our country. Too many years. Too many decades now."Trump said federal authorities are coordinating with local officials."We grieve for the terrible loss of life and send our support to everyone affected by this absolutely horrific attack," Trump said.Trump has ordered US flags at federal facilities be flown at half-staff.The-CNN-Wire 7385

The Smithsonian announced the reopening of two prominent Washington, D.C., area attractions that have been shuttered during the spread of the coronavirus.The National Zoo located in Washington and the National Air and Space Museum in nearby Chantilly, Virginia, are scheduled to reopen Friday with a number of safety precautions in place. All other Smithsonian attractions will remain closed. Most other prominent D.C. destinations, including the White House and Capitol, also remain closed to visitors.Both at the zoo and the National Air and Space Museum, all visitors age 6 and over will be required to wear face coverings. The zoo and museum are also requiring timed tickets, and has scaled back its hours to close at 4 p.m.“As a public entity, we thrive on serving our visitors and making our collections readily available to them, virtually and in person,” said Lonnie Bunch, Secretary of the Smithsonian. “However, the safety and well-being of our staff, visitors and volunteers come first and are paramount, so we are taking a deliberate, phased and cautious approach to reopening. Our goal is to be safe and measured in order to adjust and pivot as necessary.” 1177

The U.S. regulators who will decide the fate of COVID-19 vaccines are taking an unusual step: Asking outside scientists if their standards are high enough.The Food and Drug Administration may have to decide by year’s end whether to allow use of the first vaccines against the virus. Thursday, a federal advisory committee pulls back the curtain on that decision process, debating whether the guidelines FDA has set for vaccine developers are rigorous enough.“We will not cut corners, and we will only use science and data to make that determination,” FDA Commissioner Stephen Hahn pledged at a meeting of the Milken Institute Wednesday.Exactly how much data his agency needs to be sure a vaccine is safe and effective is a key question for the advisers. An even bigger one: If the FDA allows emergency use of a vaccine before final testing is finished, will that destroy chances of ever learning just how well that shot -- and maybe competitors still being studied -- really work?“We can’t lose sight of the fact that it is in our societal interest to see these trials to completion,” said Dr. Luciana Borio, a former FDA acting chief scientist who will be watching the advisers’ debate.Plus, multiple vaccines are being studied -- shots made with different technologies that each have pros and cons.“The first vaccine is not necessarily the best vaccine,” cautioned Dr. M. Miles Braun, a former FDA scientist now with Georgetown University School of Medicine. If the trials aren’t allowed to finish, it may be difficult or impossible to ever know for sure.It’s a critical moment in FDA’s 114-year history. The government has spent billions to race a vaccine through a research process that usually takes years, and FDA faces unprecedented pressure from the Trump administration, fueling public skepticism that politics could overrule science.Interest is so high, FDA is airing the meeting on YouTube. Here are some key issues the committee will discuss:HOW MUCH EVIDENCE IS NEEDED?FDA is requiring manufacturers to do studies of at least 30,000 people to prove if a vaccine protects and how safe it is. Those studies must include adequate numbers of people at highest risk from COVID-19 -- older adults, minorities and anyone with underlying health problems.FDA has made clear that any vaccine must be at least 50% effective. And while the studies are designed to run for two years, companies may get enough evidence the shots are protective -- in at least some people -- to stop the trials early and seek what’s called an “emergency use authorization” for wider vaccinations.Despite White House objections, the FDA told vaccine makers earlier this month not to seek that speedier review until they’ve tracked at least half their trial participants for two months. With other vaccines, that’s about the amount of time when major side effects crop up.That’s not long enough, said the head of the non-profit ECRI Institute, which reviews medical technology for hospitals and insurers. In comments submitted to the advisory committee, ECRI’s Dr. Marcus Schabacker said FDA should require six months of follow-up.“Doing any less would simply risk too much, and the consequences may be severe,” he wrote. “A weak vaccine that loses public trust could poison the well for epidemic control for many years.”WOULD EMERGENCY USE DERAIL FULL ANSWERS ABOUT VACCINES?Normally when a study ends because of evidence that a vaccine is working, the participants who got dummy shots are offered the real thing.But if FDA allows emergency use of a COVID-19 vaccine, that’s not the same as having full proof the shot works, Borio cautioned.And if the participants in the placebo group are immediately offered the real shot, researchers may not be able to get answers about all the high-risk groups in the study — or tell how long the vaccine’s protection lasts, a process expected to take many more months.But Pfizer Inc., which with Germany’s BioNTech is developing one of the leading candidates, told FDA that if it’s granted emergency use authorization, it “would have an ethical obligation” to alert study participants who got a placebo and allow them vaccine access. The company wants FDA to look into “other scientifically and statistically sound methods” to determine long-term safety and effectiveness.Pfizer’s stance is likely to face pushback. The Infectious Diseases Society of America states that FDA’s panelists “should insist” that vaccine developers “present a compelling case” for how they will complete their trials if FDA grants early authorization of their vaccine.Clearing a vaccine based on premature or faulty data “could cause more harm” by “further eroding public confidence in all vaccines,” the group said.It’s an unprecedented dilemma. The FDA has previously allowed emergency use of only one vaccine, a decades-old shot that in 2005 was authorized to prevent anthrax poisoning.This time around, multiple COVID-19 vaccines are in the pipeline. Pfizer competitor Johnson & Johnson cautioned that early FDA clearance of one vaccine could “jeopardize integrity” of other ongoing trials if patients decide to drop out to seek the first cleared shot instead.The company asked regulators to explain what options are available to ensure completion of all ongoing COVID-19 vaccine trials.WHAT ABOUT LONG-TERM SAFETY MONITORING?Even a study of 30,000 people cannot spot a side effect that only strikes 1 in 100,000. So the government is planning extra scrutiny of every COVID-19 vaccine to hit the market.At first there will be limited doses given to just certain high-risk people -- and those early recipients are to get text messages daily for the first week after vaccination, and then weekly out to six weeks, asking how they’re feeling.FDA also will be checking databases of electronic health records and insurance claims, looking for any red flags.“There’s a kind of tracking that has to take place here on a massive basis that hasn’t taken place before,” said Dr. Jesse Goodman of Georgetown University, a former director of the FDA’s vaccine and biologics center.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 6274